Bill · H.R. 6412· House(119-HR-6412)
Independence Investment Fund Act
- Introduced
- 12/3/2025
- Last activity
- 12/3/2025 — Referred to the House Committee on Financial Services.
- Sponsored by
- Pete Sessions
- Cosponsors
- - 1 - 5
- Introduced
- In Committee
What this bill would do
This bill establishes the Independence Investment Fund within the Department of the Treasury. The Fund is designed to invest in companies developing critical and emerging technologies, with a specific priority on biotechnology. These investments aim to strengthen the national and economic security of the United States. The Fund will operate through an independent managing entity and is overseen by a supervisory board. Additionally, an advisory board will initially help establish the roadmap and operating procedures for the Fund.
Yes· 3 of 9
Does this put more money into scientific research?+7
The fund provides significant capital specifically for the development of emerging technologies like biotechnology.
Is this likely to grow the economy?+6
By funding emerging technologies and signaling priorities to the private sector, the bill aims to enhance economic security and growth.
Would business owners be better off under this?+6
The bill provides new sources of equity investment for owners of technology companies.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Support for Emerging Technologies: The Fund aims to invest in companies developing critical and emerging technologies to improve national and economic security (Section 3(b)(1)).
-
Protection Against Foreign Investment Risks: The Fund serves as an alternative source of financial support for companies that may be vulnerable to "adversarial investment" (Section 3(b)(4)).
-
Encouraging Private Investment: By signaling technology priorities, the Fund intends to unlock private capital to support various companies (Section 3(b)(2)).
-
Economic Sustainability: The Fund is designed to make investments that generate financial returns, allowing it to sustain itself over time (Section 3(b)(3)).
-
Priority for Biotechnology: The bill specifically identifies biotechnology as a priority area for the Fund's investments (Section 3(d)).
Potential Negative Impacts for People
-
Restrictions on Company Partnerships: Portfolio companies may be prohibited from accepting investments from entities established in foreign entities of concern (Section 3(g)(3)(C)(vi)).
-
Investment Pull-back Provision: The Fund may have the option to sell its equity back to a portfolio company if the company develops in a direction that goes against the Fund's objectives (Section 3(g)(3)(C)(vii)).
-
Reporting Burdens: Portfolio companies may be subject to specific disclosure and reporting requirements (Section 3(g)(3)(B)(i)).
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Economy And Finance
- Improves Economic Growth+6Increases Job Creation+5Improves Small Business Support+4
- Demographic And Interest Groups
- Good For Business Owners+6Good For Students+2
- Education And Technology
- Increases Scientific Research Funding+7
- National Security And Foreign Policy
- Improves Cybersecurity Defense+5
- Governance And Ideology
- Improves Government Transparency+3
- Healthcare
- Improves Healthcare Access+3
- 4/27/2026
- 1 Cosponsor added.
- 12/3/2025
- Referred to the House Committee on Financial Services.
- 5 Cosponsors added.
- Introduced in House
Stephanie BiceRepublican · Oklahoma
Donald DavisDemocrat · North Carolina
Chrissy HoulahanDemocrat · Pennsylvania
Ro KhannaDemocrat · California
April McClain DelaneyDemocrat · Maryland
Eugene VindmanDemocrat · Virginia